VFA
BEAT

Virtus Fund Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

Virtus Fund Advisers’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,252
Closed -$16K – 2733
2014
Q2 		$16K Buy
+2,252
New +$17.9K ﹤0.01% 2592

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Virtus Fund Advisers's BEAT Position: Q3 2014 in Review

Virtus Fund Advisers sold out of BioTelemetry, Inc. (BEAT) in Q3 2014, closing a stake of 2,252 shares — an estimated $16K sold.

Virtus Fund Advisers first reported a position in BEAT in Q2 2014 and held it in 1 quarter. The position peaked at $16K in Q2 2014. 85 funds tracked by Wall St. Rank hold BEAT as of Q3 2014.

  • Virtus Fund Advisers reported no remaining BioTelemetry, Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 2,252 BioTelemetry, Inc. shares in Q3 2014, an estimated $16K.
  • Virtus Fund Advisers first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's BioTelemetry, Inc. position peaked at $16K in Q2 2014.
  • 85 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.